Article

Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades ago

2020-11-06

Abstract excerpt

<h4>ABSTRACT</h4> Combinatorial antibody libraries not only effectively reduce antibody discovery to a numbers game, but enable documentation of the history of antibody responses in an individual. The SARS-CoV-2 pandemic has prompted a wider application of this technology to meet the public health challenge of pandemic threats in the modern era. Herein, we used a combinatorial human antibody library constructed 2...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fb5d54cb-56d2-5b80-8007-76564fc54511
DOI: 10.1101/2020.11.06.370676

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades agoDOI 10.1101/2020.11.06.370676Read

Optimizing a Human Monoclonal Antibody for Better Neutralization of SARS-CoV-2Semantic proximity Read

Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralizationSemantic proximity Read

Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domainSemantic proximity Read

A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2Semantic proximity Read

Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patientsSemantic proximity Read

Characterization of neutralizing antibodies from a SARS-CoV-2 infected individualSemantic proximity Read

AI-based antibody discovery platform identifies novel, diverse and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strainsSemantic proximity Read

Fully human single-domain antibodies against SARS-CoV-2Semantic proximity Read

Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylacticsSemantic proximity Read

Neutralizing antibodies targeting the SARS‐CoV‐2 receptor binding domain isolated from a naïve human antibody librarySemantic proximity Read

Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infectionSemantic proximity Read

Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody librarySemantic proximity Read